Companies › Remedy Robotics
OEM · San Francisco
Remedy Robotics
Develops the N1 robotic catheter system for emergency neurointerventional procedures such as thrombectomies.
About
Remedy Robotics builds an AI-powered endovascular robotic system for endovascular intervention. The company presents its work as a response to cardiovascular diseases such as stroke, heart attack and bleeding, and notes that endovascular intervention is the gold-standard treatment that remains out of reach for most patients; the page states that fewer than 3% of eligible stroke patients worldwide can access timely endovascular intervention. The Remedy system is described as providing physicians with tool control and 3D visualization, and as including teleoperation and automation to extend expert care. The page states Remedy Robotics has achieved world-first clinical milestones, including entirely robotic neurointerventional procedures and entirely remotely controlled neurointerventional procedures.
Summary drawn from the official website, reviewed 2026-11-21.
Recent developments
Announced US $62 million in new funding to support upcoming clinical trials; a portion of the investment came from the University of California system. Source: spectrum.ieee.org
In our stories
No published story names this company yet.